nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—Dipivefrin—glaucoma	0.4	1	CrCtD
Epinephrine—TNF—glaucoma	0.106	1	CbGaD
Epinephrine—Salbutamol—Carteolol—glaucoma	0.0738	0.5	CrCrCtD
Epinephrine—Salbutamol—Levobunolol—glaucoma	0.0738	0.5	CrCrCtD
Epinephrine—ADRB2—Levobunolol—glaucoma	0.0136	0.0484	CbGbCtD
Epinephrine—ADRB2—Metipranolol—glaucoma	0.0136	0.0484	CbGbCtD
Epinephrine—ADRB1—Levobunolol—glaucoma	0.0134	0.0477	CbGbCtD
Epinephrine—ADRB1—Metipranolol—glaucoma	0.0134	0.0477	CbGbCtD
Epinephrine—ADRB3—Timolol—glaucoma	0.0123	0.0438	CbGbCtD
Epinephrine—ADRA2C—Apraclonidine—glaucoma	0.0118	0.042	CbGbCtD
Epinephrine—ADRA2C—Brimonidine—glaucoma	0.0118	0.042	CbGbCtD
Epinephrine—ADRB2—Carteolol—glaucoma	0.0116	0.0412	CbGbCtD
Epinephrine—ADRB1—Carteolol—glaucoma	0.0114	0.0406	CbGbCtD
Epinephrine—ADRA2B—Brimonidine—glaucoma	0.0112	0.0398	CbGbCtD
Epinephrine—ADRA2B—Apraclonidine—glaucoma	0.0112	0.0398	CbGbCtD
Epinephrine—SLC22A1—Latanoprost—glaucoma	0.0101	0.0358	CbGbCtD
Epinephrine—ADRA2C—Dipivefrin—glaucoma	0.00944	0.0335	CbGbCtD
Epinephrine—ADRA2B—Dipivefrin—glaucoma	0.00895	0.0318	CbGbCtD
Epinephrine—ADRB2—Dipivefrin—glaucoma	0.00826	0.0293	CbGbCtD
Epinephrine—ADRB2—Betaxolol—glaucoma	0.00783	0.0278	CbGbCtD
Epinephrine—ADRA2A—Apraclonidine—glaucoma	0.00779	0.0277	CbGbCtD
Epinephrine—ADRA2A—Brimonidine—glaucoma	0.00779	0.0277	CbGbCtD
Epinephrine—ADRB1—Betaxolol—glaucoma	0.00771	0.0274	CbGbCtD
Epinephrine—ADRA1A—Apraclonidine—glaucoma	0.00747	0.0265	CbGbCtD
Epinephrine—ADRA2A—Dipivefrin—glaucoma	0.00623	0.0221	CbGbCtD
Epinephrine—ADRA1A—Dipivefrin—glaucoma	0.00597	0.0212	CbGbCtD
Epinephrine—ADRA1D—Clonidine—glaucoma	0.0054	0.0192	CbGbCtD
Epinephrine—ADRB2—Timolol—glaucoma	0.00504	0.0179	CbGbCtD
Epinephrine—ADRB1—Timolol—glaucoma	0.00497	0.0177	CbGbCtD
Epinephrine—ADRA2C—Clonidine—glaucoma	0.0049	0.0174	CbGbCtD
Epinephrine—ADRA2B—Clonidine—glaucoma	0.00465	0.0165	CbGbCtD
Epinephrine—SLC22A5—Clonidine—glaucoma	0.0045	0.016	CbGbCtD
Epinephrine—ADRA1B—Clonidine—glaucoma	0.00393	0.014	CbGbCtD
Epinephrine—SLC22A1—Clonidine—glaucoma	0.00373	0.0132	CbGbCtD
Epinephrine—ADRA2A—Clonidine—glaucoma	0.00323	0.0115	CbGbCtD
Epinephrine—ADRA1A—Clonidine—glaucoma	0.0031	0.011	CbGbCtD
Epinephrine—CYP1A2—Betaxolol—glaucoma	0.00238	0.00847	CbGbCtD
Epinephrine—CYP2C9—Diclofenamide—glaucoma	0.00189	0.00672	CbGbCtD
Epinephrine—CYP2C9—Dorzolamide—glaucoma	0.00183	0.00649	CbGbCtD
Epinephrine—CYP2C9—Methazolamide—glaucoma	0.00163	0.00578	CbGbCtD
Epinephrine—CYP3A4—Pilocarpine—glaucoma	0.0014	0.00498	CbGbCtD
Epinephrine—CYP1A2—Clonidine—glaucoma	0.00131	0.00464	CbGbCtD
Epinephrine—CYP3A4—Brinzolamide—glaucoma	0.0011	0.00391	CbGbCtD
Epinephrine—CYP3A4—Dorzolamide—glaucoma	0.00106	0.00377	CbGbCtD
Epinephrine—CYP3A4—Methazolamide—glaucoma	0.000946	0.00336	CbGbCtD
Epinephrine—CYP3A4—Acetazolamide—glaucoma	0.000756	0.00269	CbGbCtD
Epinephrine—CYP3A4—Clonidine—glaucoma	0.000684	0.00243	CbGbCtD
Epinephrine—ADRB2—Treprostinil—Latanoprost—glaucoma	0.000597	1	CbGdCrCtD
Epinephrine—Hypertension—Metipranolol—glaucoma	0.000182	0.00449	CcSEcCtD
Epinephrine—Hypoglycaemia—Pilocarpine—glaucoma	0.000181	0.00445	CcSEcCtD
Epinephrine—Palpitations—Carteolol—glaucoma	0.000173	0.00426	CcSEcCtD
Epinephrine—Erythema—Latanoprost—glaucoma	0.000172	0.00423	CcSEcCtD
Epinephrine—Palpitations—Levobunolol—glaucoma	0.000163	0.00403	CcSEcCtD
Epinephrine—Haemorrhage—Apraclonidine—glaucoma	0.000158	0.00388	CcSEcCtD
Epinephrine—Chest pain—Levobunolol—glaucoma	0.000157	0.00388	CcSEcCtD
Epinephrine—Drowsiness—Acetazolamide—glaucoma	0.000157	0.00387	CcSEcCtD
Epinephrine—Somnolence—Metipranolol—glaucoma	0.000153	0.00378	CcSEcCtD
Epinephrine—Drowsiness—Brimonidine—glaucoma	0.000151	0.00371	CcSEcCtD
Epinephrine—Hyperhidrosis—Carbachol—glaucoma	0.000148	0.00365	CcSEcCtD
Epinephrine—Chest pain—Latanoprost—glaucoma	0.000146	0.0036	CcSEcCtD
Epinephrine—Hyperglycaemia—Dorzolamide—glaucoma	0.000146	0.00359	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Latanoprost—glaucoma	0.000145	0.00357	CcSEcCtD
Epinephrine—Insomnia—Carteolol—glaucoma	0.000144	0.00356	CcSEcCtD
Epinephrine—Cerebrovascular accident—Clonidine—glaucoma	0.000144	0.00354	CcSEcCtD
Epinephrine—Acute coronary syndrome—Dorzolamide—glaucoma	0.000142	0.00349	CcSEcCtD
Epinephrine—Paraesthesia—Diclofenamide—glaucoma	0.000141	0.00347	CcSEcCtD
Epinephrine—Myocardial infarction—Dorzolamide—glaucoma	0.000141	0.00347	CcSEcCtD
Epinephrine—Arrhythmia—Apraclonidine—glaucoma	0.000141	0.00347	CcSEcCtD
Epinephrine—Hypoaesthesia—Acetazolamide—glaucoma	0.00014	0.00345	CcSEcCtD
Epinephrine—Somnolence—Diclofenamide—glaucoma	0.00014	0.00344	CcSEcCtD
Epinephrine—Blood pressure increased—Timolol—glaucoma	0.000138	0.0034	CcSEcCtD
Epinephrine—Mental disorder—Apraclonidine—glaucoma	0.000138	0.0034	CcSEcCtD
Epinephrine—Sweating—Dorzolamide—glaucoma	0.000138	0.0034	CcSEcCtD
Epinephrine—Nervous system disorder—Latanoprost—glaucoma	0.000137	0.00338	CcSEcCtD
Epinephrine—Erythema—Apraclonidine—glaucoma	0.000137	0.00338	CcSEcCtD
Epinephrine—Disorientation—Betaxolol—glaucoma	0.000137	0.00338	CcSEcCtD
Epinephrine—Skin disorder—Latanoprost—glaucoma	0.000136	0.00335	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Diclofenamide—glaucoma	0.000136	0.00334	CcSEcCtD
Epinephrine—Paraesthesia—Levobunolol—glaucoma	0.000136	0.00334	CcSEcCtD
Epinephrine—Tension—Apraclonidine—glaucoma	0.000135	0.00332	CcSEcCtD
Epinephrine—Acute coronary syndrome—Pilocarpine—glaucoma	0.000134	0.0033	CcSEcCtD
Epinephrine—Myocardial infarction—Pilocarpine—glaucoma	0.000133	0.00328	CcSEcCtD
Epinephrine—Nervousness—Apraclonidine—glaucoma	0.000133	0.00328	CcSEcCtD
Epinephrine—Erythema—Bimatoprost—glaucoma	0.000133	0.00328	CcSEcCtD
Epinephrine—Flushing—Acetazolamide—glaucoma	0.000131	0.00322	CcSEcCtD
Epinephrine—Tension—Bimatoprost—glaucoma	0.00013	0.00321	CcSEcCtD
Epinephrine—Sweating—Pilocarpine—glaucoma	0.00013	0.00321	CcSEcCtD
Epinephrine—Paraesthesia—Methazolamide—glaucoma	0.00013	0.0032	CcSEcCtD
Epinephrine—Nervousness—Bimatoprost—glaucoma	0.000129	0.00318	CcSEcCtD
Epinephrine—Renal impairment—Betaxolol—glaucoma	0.000129	0.00318	CcSEcCtD
Epinephrine—Somnolence—Methazolamide—glaucoma	0.000129	0.00317	CcSEcCtD
Epinephrine—Hallucination—Dorzolamide—glaucoma	0.000128	0.00317	CcSEcCtD
Epinephrine—Hypoaesthesia—Brinzolamide—glaucoma	0.000126	0.00311	CcSEcCtD
Epinephrine—Hypoglycaemia—Betaxolol—glaucoma	0.000126	0.0031	CcSEcCtD
Epinephrine—Flushing—Brimonidine—glaucoma	0.000125	0.00309	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Methazolamide—glaucoma	0.000125	0.00308	CcSEcCtD
Epinephrine—Pulmonary oedema—Timolol—glaucoma	0.000123	0.00303	CcSEcCtD
Epinephrine—Hypoaesthesia—Pilocarpine—glaucoma	0.000121	0.00299	CcSEcCtD
Epinephrine—Palpitations—Apraclonidine—glaucoma	0.000121	0.00299	CcSEcCtD
Epinephrine—Arrhythmia—Brimonidine—glaucoma	0.000121	0.00298	CcSEcCtD
Epinephrine—Psychotic disorder—Betaxolol—glaucoma	0.00012	0.00295	CcSEcCtD
Epinephrine—Mental disorder—Brimonidine—glaucoma	0.000118	0.00292	CcSEcCtD
Epinephrine—Erythema—Brimonidine—glaucoma	0.000118	0.0029	CcSEcCtD
Epinephrine—Palpitations—Bimatoprost—glaucoma	0.000117	0.00289	CcSEcCtD
Epinephrine—Chest pain—Apraclonidine—glaucoma	0.000117	0.00288	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.000116	0.00286	CcSEcCtD
Epinephrine—Arrhythmia—Dorzolamide—glaucoma	0.000115	0.00284	CcSEcCtD
Epinephrine—Hypertension—Bimatoprost—glaucoma	0.000115	0.00283	CcSEcCtD
Epinephrine—Dizziness—Metipranolol—glaucoma	0.000114	0.00281	CcSEcCtD
Epinephrine—Arrhythmia—Brinzolamide—glaucoma	0.000113	0.00279	CcSEcCtD
Epinephrine—Flushing—Pilocarpine—glaucoma	0.000113	0.00279	CcSEcCtD
Epinephrine—Chest pain—Bimatoprost—glaucoma	0.000113	0.00279	CcSEcCtD
Epinephrine—Agitation—Acetazolamide—glaucoma	0.000113	0.00278	CcSEcCtD
Epinephrine—Mental disorder—Travoprost—glaucoma	0.000113	0.00278	CcSEcCtD
Epinephrine—Erythema—Dorzolamide—glaucoma	0.000112	0.00277	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.000112	0.00277	CcSEcCtD
Epinephrine—Disorientation—Timolol—glaucoma	0.000112	0.00276	CcSEcCtD
Epinephrine—Erythema—Travoprost—glaucoma	0.000112	0.00276	CcSEcCtD
Epinephrine—Hypokalaemia—Betaxolol—glaucoma	0.000112	0.00275	CcSEcCtD
Epinephrine—Mental disorder—Brinzolamide—glaucoma	0.000111	0.00274	CcSEcCtD
Epinephrine—Erythema—Brinzolamide—glaucoma	0.000111	0.00272	CcSEcCtD
Epinephrine—Tension—Dorzolamide—glaucoma	0.00011	0.00272	CcSEcCtD
Epinephrine—Nervous system disorder—Apraclonidine—glaucoma	0.00011	0.0027	CcSEcCtD
Epinephrine—Nervousness—Dorzolamide—glaucoma	0.000109	0.00269	CcSEcCtD
Epinephrine—Arrhythmia—Pilocarpine—glaucoma	0.000109	0.00269	CcSEcCtD
Epinephrine—Skin disorder—Apraclonidine—glaucoma	0.000109	0.00268	CcSEcCtD
Epinephrine—Drowsiness—Clonidine—glaucoma	0.000109	0.00267	CcSEcCtD
Epinephrine—Tension—Brinzolamide—glaucoma	0.000108	0.00267	CcSEcCtD
Epinephrine—Nervousness—Brinzolamide—glaucoma	0.000107	0.00265	CcSEcCtD
Epinephrine—Nervous system disorder—Bimatoprost—glaucoma	0.000106	0.00262	CcSEcCtD
Epinephrine—Dizziness—Carteolol—glaucoma	0.000106	0.0026	CcSEcCtD
Epinephrine—Skin disorder—Bimatoprost—glaucoma	0.000105	0.0026	CcSEcCtD
Epinephrine—Tension—Pilocarpine—glaucoma	0.000104	0.00257	CcSEcCtD
Epinephrine—Sweating—Clonidine—glaucoma	0.000104	0.00256	CcSEcCtD
Epinephrine—Palpitations—Brimonidine—glaucoma	0.000104	0.00256	CcSEcCtD
Epinephrine—Dizziness—Diclofenamide—glaucoma	0.000104	0.00256	CcSEcCtD
Epinephrine—Nervousness—Pilocarpine—glaucoma	0.000103	0.00254	CcSEcCtD
Epinephrine—Hypoglycaemia—Timolol—glaucoma	0.000103	0.00253	CcSEcCtD
Epinephrine—Nausea—Metipranolol—glaucoma	0.000102	0.00252	CcSEcCtD
Epinephrine—Cerebrovascular accident—Timolol—glaucoma	0.000102	0.00252	CcSEcCtD
Epinephrine—Hypertension—Brimonidine—glaucoma	0.000102	0.0025	CcSEcCtD
Epinephrine—Agitation—Brinzolamide—glaucoma	0.000102	0.0025	CcSEcCtD
Epinephrine—Dizziness—Carbachol—glaucoma	0.000101	0.0025	CcSEcCtD
Epinephrine—Insomnia—Apraclonidine—glaucoma	0.000101	0.00249	CcSEcCtD
Epinephrine—Paraesthesia—Apraclonidine—glaucoma	0.0001	0.00248	CcSEcCtD
Epinephrine—Chest pain—Brimonidine—glaucoma	0.0001	0.00247	CcSEcCtD
Epinephrine—Vomiting—Diclofenamide—glaucoma	9.98e-05	0.00246	CcSEcCtD
Epinephrine—Dizziness—Levobunolol—glaucoma	9.98e-05	0.00246	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	9.95e-05	0.00245	CcSEcCtD
Epinephrine—Somnolence—Apraclonidine—glaucoma	9.95e-05	0.00245	CcSEcCtD
Epinephrine—Palpitations—Dorzolamide—glaucoma	9.93e-05	0.00245	CcSEcCtD
Epinephrine—Palpitations—Travoprost—glaucoma	9.89e-05	0.00244	CcSEcCtD
Epinephrine—Insomnia—Bimatoprost—glaucoma	9.81e-05	0.00242	CcSEcCtD
Epinephrine—Palpitations—Brinzolamide—glaucoma	9.77e-05	0.00241	CcSEcCtD
Epinephrine—Agitation—Pilocarpine—glaucoma	9.76e-05	0.00241	CcSEcCtD
Epinephrine—Vomiting—Carbachol—glaucoma	9.75e-05	0.0024	CcSEcCtD
Epinephrine—Hypertension—Dorzolamide—glaucoma	9.71e-05	0.00239	CcSEcCtD
Epinephrine—Hallucination—Clonidine—glaucoma	9.7e-05	0.00239	CcSEcCtD
Epinephrine—Hypoaesthesia—Clonidine—glaucoma	9.7e-05	0.00239	CcSEcCtD
Epinephrine—Hypertension—Travoprost—glaucoma	9.66e-05	0.00238	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Apraclonidine—glaucoma	9.66e-05	0.00238	CcSEcCtD
Epinephrine—Somnolence—Bimatoprost—glaucoma	9.64e-05	0.00238	CcSEcCtD
Epinephrine—Chest pain—Dorzolamide—glaucoma	9.57e-05	0.00236	CcSEcCtD
Epinephrine—Hyperglycaemia—Betaxolol—glaucoma	9.56e-05	0.00236	CcSEcCtD
Epinephrine—Hypertension—Brinzolamide—glaucoma	9.54e-05	0.00235	CcSEcCtD
Epinephrine—Chest pain—Travoprost—glaucoma	9.53e-05	0.00235	CcSEcCtD
Epinephrine—Nausea—Carteolol—glaucoma	9.49e-05	0.00234	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	9.46e-05	0.00233	CcSEcCtD
Epinephrine—Nervous system disorder—Brimonidine—glaucoma	9.42e-05	0.00232	CcSEcCtD
Epinephrine—Chest pain—Brinzolamide—glaucoma	9.41e-05	0.00232	CcSEcCtD
Epinephrine—Palpitations—Pilocarpine—glaucoma	9.39e-05	0.00231	CcSEcCtD
Epinephrine—Tachycardia—Brimonidine—glaucoma	9.38e-05	0.00231	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Bimatoprost—glaucoma	9.37e-05	0.00231	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	9.34e-05	0.0023	CcSEcCtD
Epinephrine—Skin disorder—Brimonidine—glaucoma	9.33e-05	0.0023	CcSEcCtD
Epinephrine—Nausea—Diclofenamide—glaucoma	9.33e-05	0.0023	CcSEcCtD
Epinephrine—Acute coronary syndrome—Betaxolol—glaucoma	9.32e-05	0.0023	CcSEcCtD
Epinephrine—Myocardial infarction—Betaxolol—glaucoma	9.26e-05	0.00228	CcSEcCtD
Epinephrine—Dizziness—Latanoprost—glaucoma	9.26e-05	0.00228	CcSEcCtD
Epinephrine—Vomiting—Methazolamide—glaucoma	9.19e-05	0.00227	CcSEcCtD
Epinephrine—Hypertension—Pilocarpine—glaucoma	9.17e-05	0.00226	CcSEcCtD
Epinephrine—Nausea—Carbachol—glaucoma	9.1e-05	0.00224	CcSEcCtD
Epinephrine—Sweating—Betaxolol—glaucoma	9.06e-05	0.00223	CcSEcCtD
Epinephrine—Chest pain—Pilocarpine—glaucoma	9.04e-05	0.00223	CcSEcCtD
Epinephrine—Paraesthesia—Acetazolamide—glaucoma	8.99e-05	0.00221	CcSEcCtD
Epinephrine—Nausea—Levobunolol—glaucoma	8.97e-05	0.00221	CcSEcCtD
Epinephrine—Nervous system disorder—Travoprost—glaucoma	8.96e-05	0.00221	CcSEcCtD
Epinephrine—Tachycardia—Travoprost—glaucoma	8.92e-05	0.0022	CcSEcCtD
Epinephrine—Somnolence—Acetazolamide—glaucoma	8.9e-05	0.00219	CcSEcCtD
Epinephrine—Skin disorder—Travoprost—glaucoma	8.87e-05	0.00219	CcSEcCtD
Epinephrine—Hyperhidrosis—Dorzolamide—glaucoma	8.87e-05	0.00219	CcSEcCtD
Epinephrine—Nervous system disorder—Brinzolamide—glaucoma	8.85e-05	0.00218	CcSEcCtD
Epinephrine—Tachycardia—Brinzolamide—glaucoma	8.8e-05	0.00217	CcSEcCtD
Epinephrine—Skin disorder—Brinzolamide—glaucoma	8.76e-05	0.00216	CcSEcCtD
Epinephrine—Arrhythmia—Clonidine—glaucoma	8.7e-05	0.00215	CcSEcCtD
Epinephrine—Insomnia—Brimonidine—glaucoma	8.69e-05	0.00214	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Acetazolamide—glaucoma	8.64e-05	0.00213	CcSEcCtD
Epinephrine—Paraesthesia—Brimonidine—glaucoma	8.63e-05	0.00213	CcSEcCtD
Epinephrine—Nausea—Methazolamide—glaucoma	8.59e-05	0.00212	CcSEcCtD
Epinephrine—Somnolence—Brimonidine—glaucoma	8.54e-05	0.0021	CcSEcCtD
Epinephrine—Mental disorder—Clonidine—glaucoma	8.54e-05	0.0021	CcSEcCtD
Epinephrine—Erythema—Clonidine—glaucoma	8.48e-05	0.00209	CcSEcCtD
Epinephrine—Tachycardia—Pilocarpine—glaucoma	8.46e-05	0.00208	CcSEcCtD
Epinephrine—Hypoaesthesia—Betaxolol—glaucoma	8.44e-05	0.00208	CcSEcCtD
Epinephrine—Hallucination—Betaxolol—glaucoma	8.44e-05	0.00208	CcSEcCtD
Epinephrine—Hyperhidrosis—Pilocarpine—glaucoma	8.38e-05	0.00207	CcSEcCtD
Epinephrine—Tension—Clonidine—glaucoma	8.32e-05	0.00205	CcSEcCtD
Epinephrine—Insomnia—Dorzolamide—glaucoma	8.3e-05	0.00204	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Brimonidine—glaucoma	8.29e-05	0.00204	CcSEcCtD
Epinephrine—Nervousness—Clonidine—glaucoma	8.24e-05	0.00203	CcSEcCtD
Epinephrine—Paraesthesia—Dorzolamide—glaucoma	8.24e-05	0.00203	CcSEcCtD
Epinephrine—Insomnia—Brinzolamide—glaucoma	8.16e-05	0.00201	CcSEcCtD
Epinephrine—Somnolence—Dorzolamide—glaucoma	8.16e-05	0.00201	CcSEcCtD
Epinephrine—Paraesthesia—Brinzolamide—glaucoma	8.1e-05	0.002	CcSEcCtD
Epinephrine—Somnolence—Brinzolamide—glaucoma	8.02e-05	0.00198	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Travoprost—glaucoma	7.89e-05	0.00194	CcSEcCtD
Epinephrine—Flushing—Betaxolol—glaucoma	7.87e-05	0.00194	CcSEcCtD
Epinephrine—Insomnia—Pilocarpine—glaucoma	7.84e-05	0.00193	CcSEcCtD
Epinephrine—Hyperglycaemia—Timolol—glaucoma	7.81e-05	0.00192	CcSEcCtD
Epinephrine—Agitation—Clonidine—glaucoma	7.8e-05	0.00192	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Brinzolamide—glaucoma	7.79e-05	0.00192	CcSEcCtD
Epinephrine—Paraesthesia—Pilocarpine—glaucoma	7.78e-05	0.00192	CcSEcCtD
Epinephrine—Somnolence—Pilocarpine—glaucoma	7.71e-05	0.0019	CcSEcCtD
Epinephrine—Arrhythmia—Betaxolol—glaucoma	7.58e-05	0.00187	CcSEcCtD
Epinephrine—Palpitations—Clonidine—glaucoma	7.5e-05	0.00185	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Pilocarpine—glaucoma	7.48e-05	0.00184	CcSEcCtD
Epinephrine—Mental disorder—Betaxolol—glaucoma	7.43e-05	0.00183	CcSEcCtD
Epinephrine—Sweating—Timolol—glaucoma	7.4e-05	0.00182	CcSEcCtD
Epinephrine—Dizziness—Apraclonidine—glaucoma	7.4e-05	0.00182	CcSEcCtD
Epinephrine—Erythema—Betaxolol—glaucoma	7.38e-05	0.00182	CcSEcCtD
Epinephrine—Tension—Betaxolol—glaucoma	7.25e-05	0.00179	CcSEcCtD
Epinephrine—Chest pain—Clonidine—glaucoma	7.22e-05	0.00178	CcSEcCtD
Epinephrine—Dizziness—Bimatoprost—glaucoma	7.17e-05	0.00177	CcSEcCtD
Epinephrine—Nervousness—Betaxolol—glaucoma	7.17e-05	0.00177	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	7.17e-05	0.00177	CcSEcCtD
Epinephrine—Vomiting—Apraclonidine—glaucoma	7.11e-05	0.00175	CcSEcCtD
Epinephrine—Hallucination—Timolol—glaucoma	6.9e-05	0.0017	CcSEcCtD
Epinephrine—Nervous system disorder—Clonidine—glaucoma	6.79e-05	0.00167	CcSEcCtD
Epinephrine—Tachycardia—Clonidine—glaucoma	6.76e-05	0.00166	CcSEcCtD
Epinephrine—Skin disorder—Clonidine—glaucoma	6.72e-05	0.00166	CcSEcCtD
Epinephrine—Hyperhidrosis—Clonidine—glaucoma	6.69e-05	0.00165	CcSEcCtD
Epinephrine—Nausea—Apraclonidine—glaucoma	6.65e-05	0.00164	CcSEcCtD
Epinephrine—Dizziness—Acetazolamide—glaucoma	6.62e-05	0.00163	CcSEcCtD
Epinephrine—Palpitations—Betaxolol—glaucoma	6.53e-05	0.00161	CcSEcCtD
Epinephrine—Nausea—Bimatoprost—glaucoma	6.44e-05	0.00159	CcSEcCtD
Epinephrine—Vomiting—Acetazolamide—glaucoma	6.36e-05	0.00157	CcSEcCtD
Epinephrine—Dizziness—Brimonidine—glaucoma	6.35e-05	0.00157	CcSEcCtD
Epinephrine—Chest pain—Betaxolol—glaucoma	6.29e-05	0.00155	CcSEcCtD
Epinephrine—Insomnia—Clonidine—glaucoma	6.26e-05	0.00154	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	6.24e-05	0.00154	CcSEcCtD
Epinephrine—Paraesthesia—Clonidine—glaucoma	6.22e-05	0.00153	CcSEcCtD
Epinephrine—Arrhythmia—Timolol—glaucoma	6.19e-05	0.00153	CcSEcCtD
Epinephrine—Somnolence—Clonidine—glaucoma	6.15e-05	0.00152	CcSEcCtD
Epinephrine—Mental disorder—Timolol—glaucoma	6.07e-05	0.0015	CcSEcCtD
Epinephrine—Dizziness—Dorzolamide—glaucoma	6.07e-05	0.0015	CcSEcCtD
Epinephrine—Dizziness—Travoprost—glaucoma	6.04e-05	0.00149	CcSEcCtD
Epinephrine—Erythema—Timolol—glaucoma	6.03e-05	0.00149	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Clonidine—glaucoma	5.98e-05	0.00147	CcSEcCtD
Epinephrine—Dizziness—Brinzolamide—glaucoma	5.96e-05	0.00147	CcSEcCtD
Epinephrine—Nausea—Acetazolamide—glaucoma	5.95e-05	0.00147	CcSEcCtD
Epinephrine—Tension—Timolol—glaucoma	5.92e-05	0.00146	CcSEcCtD
Epinephrine—Nervous system disorder—Betaxolol—glaucoma	5.91e-05	0.00146	CcSEcCtD
Epinephrine—Tachycardia—Betaxolol—glaucoma	5.88e-05	0.00145	CcSEcCtD
Epinephrine—Nervousness—Timolol—glaucoma	5.86e-05	0.00144	CcSEcCtD
Epinephrine—Skin disorder—Betaxolol—glaucoma	5.85e-05	0.00144	CcSEcCtD
Epinephrine—Vomiting—Dorzolamide—glaucoma	5.83e-05	0.00144	CcSEcCtD
Epinephrine—Hyperhidrosis—Betaxolol—glaucoma	5.83e-05	0.00144	CcSEcCtD
Epinephrine—Vomiting—Brinzolamide—glaucoma	5.73e-05	0.00141	CcSEcCtD
Epinephrine—Dizziness—Pilocarpine—glaucoma	5.73e-05	0.00141	CcSEcCtD
Epinephrine—Nausea—Brimonidine—glaucoma	5.71e-05	0.00141	CcSEcCtD
Epinephrine—Vomiting—Pilocarpine—glaucoma	5.51e-05	0.00136	CcSEcCtD
Epinephrine—Insomnia—Betaxolol—glaucoma	5.45e-05	0.00134	CcSEcCtD
Epinephrine—Nausea—Dorzolamide—glaucoma	5.45e-05	0.00134	CcSEcCtD
Epinephrine—Nausea—Travoprost—glaucoma	5.43e-05	0.00134	CcSEcCtD
Epinephrine—Paraesthesia—Betaxolol—glaucoma	5.41e-05	0.00133	CcSEcCtD
Epinephrine—Nausea—Brinzolamide—glaucoma	5.36e-05	0.00132	CcSEcCtD
Epinephrine—Palpitations—Timolol—glaucoma	5.33e-05	0.00131	CcSEcCtD
Epinephrine—Hypertension—Timolol—glaucoma	5.21e-05	0.00128	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Betaxolol—glaucoma	5.2e-05	0.00128	CcSEcCtD
Epinephrine—Nausea—Pilocarpine—glaucoma	5.15e-05	0.00127	CcSEcCtD
Epinephrine—Chest pain—Timolol—glaucoma	5.14e-05	0.00127	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	5.1e-05	0.00126	CcSEcCtD
Epinephrine—Nervous system disorder—Timolol—glaucoma	4.83e-05	0.00119	CcSEcCtD
Epinephrine—Skin disorder—Timolol—glaucoma	4.78e-05	0.00118	CcSEcCtD
Epinephrine—Hyperhidrosis—Timolol—glaucoma	4.76e-05	0.00117	CcSEcCtD
Epinephrine—Dizziness—Clonidine—glaucoma	4.58e-05	0.00113	CcSEcCtD
Epinephrine—Insomnia—Timolol—glaucoma	4.45e-05	0.0011	CcSEcCtD
Epinephrine—Paraesthesia—Timolol—glaucoma	4.42e-05	0.00109	CcSEcCtD
Epinephrine—Vomiting—Clonidine—glaucoma	4.4e-05	0.00108	CcSEcCtD
Epinephrine—Somnolence—Timolol—glaucoma	4.38e-05	0.00108	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Timolol—glaucoma	4.25e-05	0.00105	CcSEcCtD
Epinephrine—Nausea—Clonidine—glaucoma	4.11e-05	0.00101	CcSEcCtD
Epinephrine—Dizziness—Betaxolol—glaucoma	3.99e-05	0.000982	CcSEcCtD
Epinephrine—Vomiting—Betaxolol—glaucoma	3.83e-05	0.000944	CcSEcCtD
Epinephrine—Nausea—Betaxolol—glaucoma	3.58e-05	0.000882	CcSEcCtD
Epinephrine—Dizziness—Timolol—glaucoma	3.26e-05	0.000802	CcSEcCtD
Epinephrine—Vomiting—Timolol—glaucoma	3.13e-05	0.000771	CcSEcCtD
Epinephrine—Nausea—Timolol—glaucoma	2.92e-05	0.000721	CcSEcCtD
Epinephrine—CYP1A2—Metabolism—CA1—glaucoma	4.11e-06	0.000173	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—NTRK2—glaucoma	4.06e-06	0.000171	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—SMO—glaucoma	4.04e-06	0.00017	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—EDN1—glaucoma	4.02e-06	0.000169	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—C3—glaucoma	4.02e-06	0.000169	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—SMO—glaucoma	4.01e-06	0.000168	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CTSA—glaucoma	3.98e-06	0.000167	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—SMO—glaucoma	3.96e-06	0.000166	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—C3—glaucoma	3.96e-06	0.000166	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—C3—glaucoma	3.94e-06	0.000166	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—C3—glaucoma	3.92e-06	0.000165	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—C3—glaucoma	3.91e-06	0.000164	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—HDAC9—glaucoma	3.89e-06	0.000163	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—C3—glaucoma	3.86e-06	0.000162	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CA2—glaucoma	3.76e-06	0.000158	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—ABCA1—glaucoma	3.75e-06	0.000158	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—CYP1B1—glaucoma	3.75e-06	0.000158	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—SMO—glaucoma	3.74e-06	0.000157	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—EDN1—glaucoma	3.74e-06	0.000157	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—GSTT1—glaucoma	3.72e-06	0.000156	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NTRK2—glaucoma	3.7e-06	0.000155	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—SMO—glaucoma	3.68e-06	0.000155	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.67e-06	0.000154	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.67e-06	0.000154	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NTRK2—glaucoma	3.67e-06	0.000154	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—APOE—glaucoma	3.65e-06	0.000153	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—EDN1—glaucoma	3.65e-06	0.000153	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—C3—glaucoma	3.65e-06	0.000153	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—ABCA1—glaucoma	3.65e-06	0.000153	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—CYP1B1—glaucoma	3.65e-06	0.000153	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CAV1—glaucoma	3.62e-06	0.000152	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NTRK2—glaucoma	3.62e-06	0.000152	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—NOS3—glaucoma	3.6e-06	0.000151	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—C3—glaucoma	3.59e-06	0.000151	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—C3—glaucoma	3.51e-06	0.000148	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—ABCA1—glaucoma	3.5e-06	0.000147	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—CYP1B1—glaucoma	3.5e-06	0.000147	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—NGFR—glaucoma	3.48e-06	0.000146	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—FN1—glaucoma	3.45e-06	0.000145	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NTRK2—glaucoma	3.42e-06	0.000144	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—VEGFA—glaucoma	3.42e-06	0.000144	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—NOS3—glaucoma	3.41e-06	0.000143	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—BAD—glaucoma	3.4e-06	0.000143	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—EDN1—glaucoma	3.39e-06	0.000143	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NTRK2—glaucoma	3.37e-06	0.000142	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—NTRK1—glaucoma	3.31e-06	0.000139	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—SMO—glaucoma	3.27e-06	0.000137	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—C3—glaucoma	3.26e-06	0.000137	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—VEGFA—glaucoma	3.2e-06	0.000134	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—C3—glaucoma	3.19e-06	0.000134	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NGFR—glaucoma	3.17e-06	0.000133	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CA1—glaucoma	3.17e-06	0.000133	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NGFR—glaucoma	3.14e-06	0.000132	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NGFR—glaucoma	3.1e-06	0.00013	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—TXN—glaucoma	3.1e-06	0.00013	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CTSA—glaucoma	3.07e-06	0.000129	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CDKN2B—glaucoma	3.05e-06	0.000128	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—SMO—glaucoma	3.04e-06	0.000128	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NTRK1—glaucoma	3.02e-06	0.000127	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—GSTM1—glaucoma	3e-06	0.000126	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NTRK2—glaucoma	2.99e-06	0.000126	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NTRK1—glaucoma	2.99e-06	0.000125	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—C3—glaucoma	2.96e-06	0.000125	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—CYP1B1—glaucoma	2.96e-06	0.000124	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—ABCA1—glaucoma	2.96e-06	0.000124	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—CDKN1B—glaucoma	2.95e-06	0.000124	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NTRK1—glaucoma	2.95e-06	0.000124	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NGFR—glaucoma	2.94e-06	0.000123	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—EDN1—glaucoma	2.93e-06	0.000123	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—GSTM1—glaucoma	2.92e-06	0.000123	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CA2—glaucoma	2.9e-06	0.000122	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NGFR—glaucoma	2.89e-06	0.000121	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.83e-06	0.000119	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.8e-06	0.000118	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—GSTM1—glaucoma	2.8e-06	0.000117	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NTRK1—glaucoma	2.79e-06	0.000117	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NTRK2—glaucoma	2.78e-06	0.000117	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CDKN2B—glaucoma	2.78e-06	0.000117	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CDKN2B—glaucoma	2.75e-06	0.000116	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NTRK1—glaucoma	2.75e-06	0.000115	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—NOS3—glaucoma	2.74e-06	0.000115	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—MMP9—glaucoma	2.74e-06	0.000115	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CDKN2B—glaucoma	2.72e-06	0.000114	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—NGF—glaucoma	2.69e-06	0.000113	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—EDN1—glaucoma	2.67e-06	0.000112	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—MTHFR—glaucoma	2.65e-06	0.000111	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—TXN—glaucoma	2.65e-06	0.000111	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—EDN1—glaucoma	2.64e-06	0.000111	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—EDN1—glaucoma	2.61e-06	0.00011	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—VEGFA—glaucoma	2.6e-06	0.000109	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—TP53—glaucoma	2.58e-06	0.000109	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—MTHFR—glaucoma	2.58e-06	0.000108	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CDKN2B—glaucoma	2.57e-06	0.000108	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NGFR—glaucoma	2.57e-06	0.000108	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—C3—glaucoma	2.56e-06	0.000107	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CDKN2B—glaucoma	2.53e-06	0.000106	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—MTHFR—glaucoma	2.47e-06	0.000104	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—EDN1—glaucoma	2.47e-06	0.000104	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—APOE—glaucoma	2.47e-06	0.000104	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—VEGFA—glaucoma	2.46e-06	0.000103	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NGF—glaucoma	2.45e-06	0.000103	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—CAV1—glaucoma	2.45e-06	0.000103	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NTRK1—glaucoma	2.44e-06	0.000102	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—EDN1—glaucoma	2.43e-06	0.000102	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NGF—glaucoma	2.43e-06	0.000102	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.42e-06	0.000102	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—TP53—glaucoma	2.41e-06	0.000101	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GSTT1—glaucoma	2.4e-06	0.000101	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—APOE—glaucoma	2.4e-06	0.000101	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NGF—glaucoma	2.4e-06	0.000101	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.39e-06	0.000101	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NGFR—glaucoma	2.39e-06	0.0001	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—APOE—glaucoma	2.38e-06	0.0001	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—CAV1—glaucoma	2.38e-06	9.99e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CDKN1B—glaucoma	2.37e-06	9.96e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—GSTM1—glaucoma	2.37e-06	9.95e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CAV1—glaucoma	2.36e-06	9.9e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—C3—glaucoma	2.33e-06	9.78e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—C3—glaucoma	2.31e-06	9.69e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—APOE—glaucoma	2.3e-06	9.66e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—CAV1—glaucoma	2.28e-06	9.57e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—C3—glaucoma	2.28e-06	9.57e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NGF—glaucoma	2.27e-06	9.53e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NTRK1—glaucoma	2.27e-06	9.52e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CDKN2B—glaucoma	2.25e-06	9.44e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—FN1—glaucoma	2.24e-06	9.43e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NGF—glaucoma	2.23e-06	9.37e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—BAD—glaucoma	2.22e-06	9.31e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—MMP9—glaucoma	2.2e-06	9.22e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—APOE—glaucoma	2.17e-06	9.11e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—EDN1—glaucoma	2.16e-06	9.06e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—C3—glaucoma	2.16e-06	9.05e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—APOE—glaucoma	2.15e-06	9.02e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CAV1—glaucoma	2.15e-06	9.02e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CAV1—glaucoma	2.13e-06	8.94e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—C3—glaucoma	2.12e-06	8.91e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—APOE—glaucoma	2.12e-06	8.91e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CAV1—glaucoma	2.1e-06	8.83e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—MTHFR—glaucoma	2.09e-06	8.8e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CDKN2B—glaucoma	2.09e-06	8.77e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GSTT1—glaucoma	2.05e-06	8.63e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—FN1—glaucoma	2.04e-06	8.59e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—TXN—glaucoma	2.04e-06	8.59e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—FN1—glaucoma	2.03e-06	8.51e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—BAD—glaucoma	2.02e-06	8.49e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—APOE—glaucoma	2.01e-06	8.43e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—EDN1—glaucoma	2e-06	8.42e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—BAD—glaucoma	2e-06	8.41e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—FN1—glaucoma	2e-06	8.4e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CAV1—glaucoma	1.99e-06	8.35e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NGF—glaucoma	1.98e-06	8.33e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—BAD—glaucoma	1.98e-06	8.3e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—APOE—glaucoma	1.98e-06	8.3e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—VEGFA—glaucoma	1.97e-06	8.28e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—TP53—glaucoma	1.96e-06	8.24e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CAV1—glaucoma	1.96e-06	8.22e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—APOE—glaucoma	1.95e-06	8.19e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.94e-06	8.14e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—CAV1—glaucoma	1.93e-06	8.11e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ABCA1—glaucoma	1.91e-06	8.04e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—CYP1B1—glaucoma	1.91e-06	8.04e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—FN1—glaucoma	1.89e-06	7.95e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—C3—glaucoma	1.88e-06	7.92e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—BAD—glaucoma	1.87e-06	7.86e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—FN1—glaucoma	1.86e-06	7.82e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TP53—glaucoma	1.86e-06	7.79e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—NOS3—glaucoma	1.85e-06	7.77e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NGF—glaucoma	1.84e-06	7.74e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—BAD—glaucoma	1.84e-06	7.73e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—NOS3—glaucoma	1.8e-06	7.55e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—NOS3—glaucoma	1.78e-06	7.49e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—APOE—glaucoma	1.75e-06	7.37e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—C3—glaucoma	1.75e-06	7.35e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CAV1—glaucoma	1.74e-06	7.3e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—NOS3—glaucoma	1.72e-06	7.24e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PTGS2—glaucoma	1.69e-06	7.1e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.66e-06	6.95e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—FN1—glaucoma	1.65e-06	6.95e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PTGS2—glaucoma	1.64e-06	6.91e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ABCA1—glaucoma	1.64e-06	6.87e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CYP1B1—glaucoma	1.64e-06	6.87e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—BAD—glaucoma	1.63e-06	6.87e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—APOE—glaucoma	1.63e-06	6.85e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NOS3—glaucoma	1.62e-06	6.82e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CAV1—glaucoma	1.62e-06	6.78e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NOS3—glaucoma	1.61e-06	6.76e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NOS3—glaucoma	1.59e-06	6.67e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GSTT1—glaucoma	1.58e-06	6.66e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PTGS2—glaucoma	1.58e-06	6.62e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CDKN1B—glaucoma	1.54e-06	6.49e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—FN1—glaucoma	1.54e-06	6.46e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GSTM1—glaucoma	1.53e-06	6.43e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—BAD—glaucoma	1.52e-06	6.38e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NOS3—glaucoma	1.5e-06	6.32e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TP53—glaucoma	1.49e-06	6.26e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NOS3—glaucoma	1.48e-06	6.22e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—NOS3—glaucoma	1.46e-06	6.13e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MMP9—glaucoma	1.43e-06	6.01e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CDKN1B—glaucoma	1.41e-06	5.91e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CDKN1B—glaucoma	1.39e-06	5.86e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CDKN1B—glaucoma	1.38e-06	5.78e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—MTHFR—glaucoma	1.35e-06	5.68e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PTGS2—glaucoma	1.34e-06	5.61e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NOS3—glaucoma	1.31e-06	5.52e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GSTM1—glaucoma	1.31e-06	5.49e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MMP9—glaucoma	1.3e-06	5.47e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CDKN1B—glaucoma	1.3e-06	5.47e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MMP9—glaucoma	1.29e-06	5.42e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—VEGFA—glaucoma	1.28e-06	5.4e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CDKN1B—glaucoma	1.28e-06	5.38e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MMP9—glaucoma	1.28e-06	5.36e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ABCA1—glaucoma	1.26e-06	5.3e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CYP1B1—glaucoma	1.26e-06	5.3e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—APOE—glaucoma	1.26e-06	5.29e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—CAV1—glaucoma	1.25e-06	5.24e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NOS3—glaucoma	1.22e-06	5.13e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MMP9—glaucoma	1.21e-06	5.07e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MMP9—glaucoma	1.19e-06	4.99e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—VEGFA—glaucoma	1.17e-06	4.92e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—VEGFA—glaucoma	1.16e-06	4.87e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—MTHFR—glaucoma	1.16e-06	4.86e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—VEGFA—glaucoma	1.14e-06	4.81e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CDKN1B—glaucoma	1.14e-06	4.78e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—VEGFA—glaucoma	1.08e-06	4.55e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—APOE—glaucoma	1.08e-06	4.52e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CAV1—glaucoma	1.07e-06	4.48e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—VEGFA—glaucoma	1.07e-06	4.48e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CDKN1B—glaucoma	1.06e-06	4.44e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MMP9—glaucoma	1.05e-06	4.43e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GSTM1—glaucoma	1.01e-06	4.24e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MMP9—glaucoma	9.8e-07	4.12e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TP53—glaucoma	9.71e-07	4.08e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—VEGFA—glaucoma	9.47e-07	3.98e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—NOS3—glaucoma	9.44e-07	3.96e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—MTHFR—glaucoma	8.92e-07	3.75e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TP53—glaucoma	8.84e-07	3.71e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—VEGFA—glaucoma	8.8e-07	3.7e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TP53—glaucoma	8.76e-07	3.68e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TP53—glaucoma	8.65e-07	3.63e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PTGS2—glaucoma	8.63e-07	3.62e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—APOE—glaucoma	8.31e-07	3.49e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CAV1—glaucoma	8.23e-07	3.46e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TP53—glaucoma	8.19e-07	3.44e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—NOS3—glaucoma	8.06e-07	3.39e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TP53—glaucoma	8.06e-07	3.38e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PTGS2—glaucoma	7.37e-07	3.1e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TP53—glaucoma	7.16e-07	3.01e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TP53—glaucoma	6.65e-07	2.79e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—NOS3—glaucoma	6.22e-07	2.61e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PTGS2—glaucoma	5.69e-07	2.39e-05	CbGpPWpGaD
